Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development
The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM...
Gespeichert in:
Veröffentlicht in: | Frontiers of medicine 2011-06, Vol.5 (2), p.171-177 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 177 |
---|---|
container_issue | 2 |
container_start_page | 171 |
container_title | Frontiers of medicine |
container_volume | 5 |
creator | Bian, Zhaoxiang Liu, Baoyan Moher, David Wu, Taixiang Li, Youping Shang, Hongcai Cheng, Chungwah |
description | The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered. |
doi_str_mv | 10.1007/s11684-011-0132-z |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_873494750</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>873494750</sourcerecordid><originalsourceid>FETCH-LOGICAL-c335z-db5e3bd92f0f79022756f3c30a9cbaebe4191becde211487b507a84040fa6d453</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxU1paEKSD9BLEfTQ9uBUkiXb6q2Y_oPQhTY9C9ka7Sp4LXckF7qXfvVqcRpKDhEIDdLvPTHziuI5o1eM0uZtZKxuRUkZy7vi5eFJccapkiXlXD69r1lzWlzGeEvzEjVrlHpWnHJWK1lzflb86cIUw-itSWBJTGayBm0kwRGEOWDy05Yk9GaM5HW3-fp98-3mDXEB86WxPvkwmZF0Oz9BBLIH64dcviPDgghTItGnxRwpkp2JW9KCQCz8gjHM-wxcFCcue8Pl3Xle_Pj44ab7XF5vPn3p3l-XQ1XJQ2l7CVVvFXfUNSp32MjaVUNFjRp6Az0IplgPgwXOmGibXtLGtIIK6kxthazOi1er74zh5wIx6b2PA4yjmSAsUbdNJZRoJM3kywfkbVgwdxk1U-I4c0VFpthKDRhiRHB6Rr83-Fszqo_56DUfnfPRx3z0IWte3DkvfZ7UveJfGhngKxDz07QF_O_rR1zbVbTz2x0g2BkhRu0wTMkDPib9C4h6rxk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1941684904</pqid></control><display><type>article</type><title>Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Bian, Zhaoxiang ; Liu, Baoyan ; Moher, David ; Wu, Taixiang ; Li, Youping ; Shang, Hongcai ; Cheng, Chungwah</creator><creatorcontrib>Bian, Zhaoxiang ; Liu, Baoyan ; Moher, David ; Wu, Taixiang ; Li, Youping ; Shang, Hongcai ; Cheng, Chungwah</creatorcontrib><description>The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.</description><identifier>ISSN: 2095-0217</identifier><identifier>EISSN: 2095-0225</identifier><identifier>DOI: 10.1007/s11684-011-0132-z</identifier><identifier>PMID: 21695622</identifier><language>eng</language><publisher>Heidelberg: Higher Education Press</publisher><subject>Chinese medicine ; Compilation & review ; CONSORT for TCM ; future development ; Guidelines as Topic ; Humans ; Medicine ; Medicine & Public Health ; Medicine, Chinese Traditional - standards ; Randomized Controlled Trials as Topic - standards ; Report writing ; reporting standards ; Research Report - standards ; Review</subject><ispartof>Frontiers of medicine, 2011-06, Vol.5 (2), p.171-177</ispartof><rights>Copyright reserved, 2014, Higher Education Press and Springer-Verlag Berlin Heidelberg</rights><rights>Higher Education Press and Springer-Verlag Berlin Heidelberg 2011</rights><rights>Frontiers of Medicine is a copyright of Springer, 2011.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c335z-db5e3bd92f0f79022756f3c30a9cbaebe4191becde211487b507a84040fa6d453</citedby><cites>FETCH-LOGICAL-c335z-db5e3bd92f0f79022756f3c30a9cbaebe4191becde211487b507a84040fa6d453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11684-011-0132-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11684-011-0132-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21695622$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bian, Zhaoxiang</creatorcontrib><creatorcontrib>Liu, Baoyan</creatorcontrib><creatorcontrib>Moher, David</creatorcontrib><creatorcontrib>Wu, Taixiang</creatorcontrib><creatorcontrib>Li, Youping</creatorcontrib><creatorcontrib>Shang, Hongcai</creatorcontrib><creatorcontrib>Cheng, Chungwah</creatorcontrib><title>Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development</title><title>Frontiers of medicine</title><addtitle>Front Med</addtitle><addtitle>Front. Med</addtitle><addtitle>Front Med</addtitle><description>The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.</description><subject>Chinese medicine</subject><subject>Compilation & review</subject><subject>CONSORT for TCM</subject><subject>future development</subject><subject>Guidelines as Topic</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Medicine, Chinese Traditional - standards</subject><subject>Randomized Controlled Trials as Topic - standards</subject><subject>Report writing</subject><subject>reporting standards</subject><subject>Research Report - standards</subject><subject>Review</subject><issn>2095-0217</issn><issn>2095-0225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU9r3DAQxU1paEKSD9BLEfTQ9uBUkiXb6q2Y_oPQhTY9C9ka7Sp4LXckF7qXfvVqcRpKDhEIDdLvPTHziuI5o1eM0uZtZKxuRUkZy7vi5eFJccapkiXlXD69r1lzWlzGeEvzEjVrlHpWnHJWK1lzflb86cIUw-itSWBJTGayBm0kwRGEOWDy05Yk9GaM5HW3-fp98-3mDXEB86WxPvkwmZF0Oz9BBLIH64dcviPDgghTItGnxRwpkp2JW9KCQCz8gjHM-wxcFCcue8Pl3Xle_Pj44ab7XF5vPn3p3l-XQ1XJQ2l7CVVvFXfUNSp32MjaVUNFjRp6Az0IplgPgwXOmGibXtLGtIIK6kxthazOi1er74zh5wIx6b2PA4yjmSAsUbdNJZRoJM3kywfkbVgwdxk1U-I4c0VFpthKDRhiRHB6Rr83-Fszqo_56DUfnfPRx3z0IWte3DkvfZ7UveJfGhngKxDz07QF_O_rR1zbVbTz2x0g2BkhRu0wTMkDPib9C4h6rxk</recordid><startdate>20110601</startdate><enddate>20110601</enddate><creator>Bian, Zhaoxiang</creator><creator>Liu, Baoyan</creator><creator>Moher, David</creator><creator>Wu, Taixiang</creator><creator>Li, Youping</creator><creator>Shang, Hongcai</creator><creator>Cheng, Chungwah</creator><general>Higher Education Press</general><general>SP Higher Education Press</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20110601</creationdate><title>Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development</title><author>Bian, Zhaoxiang ; Liu, Baoyan ; Moher, David ; Wu, Taixiang ; Li, Youping ; Shang, Hongcai ; Cheng, Chungwah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c335z-db5e3bd92f0f79022756f3c30a9cbaebe4191becde211487b507a84040fa6d453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Chinese medicine</topic><topic>Compilation & review</topic><topic>CONSORT for TCM</topic><topic>future development</topic><topic>Guidelines as Topic</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Medicine, Chinese Traditional - standards</topic><topic>Randomized Controlled Trials as Topic - standards</topic><topic>Report writing</topic><topic>reporting standards</topic><topic>Research Report - standards</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bian, Zhaoxiang</creatorcontrib><creatorcontrib>Liu, Baoyan</creatorcontrib><creatorcontrib>Moher, David</creatorcontrib><creatorcontrib>Wu, Taixiang</creatorcontrib><creatorcontrib>Li, Youping</creatorcontrib><creatorcontrib>Shang, Hongcai</creatorcontrib><creatorcontrib>Cheng, Chungwah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Frontiers of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bian, Zhaoxiang</au><au>Liu, Baoyan</au><au>Moher, David</au><au>Wu, Taixiang</au><au>Li, Youping</au><au>Shang, Hongcai</au><au>Cheng, Chungwah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development</atitle><jtitle>Frontiers of medicine</jtitle><stitle>Front Med</stitle><stitle>Front. Med</stitle><addtitle>Front Med</addtitle><date>2011-06-01</date><risdate>2011</risdate><volume>5</volume><issue>2</issue><spage>171</spage><epage>177</epage><pages>171-177</pages><issn>2095-0217</issn><eissn>2095-0225</eissn><abstract>The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.</abstract><cop>Heidelberg</cop><pub>Higher Education Press</pub><pmid>21695622</pmid><doi>10.1007/s11684-011-0132-z</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2095-0217 |
ispartof | Frontiers of medicine, 2011-06, Vol.5 (2), p.171-177 |
issn | 2095-0217 2095-0225 |
language | eng |
recordid | cdi_proquest_miscellaneous_873494750 |
source | MEDLINE; SpringerNature Journals |
subjects | Chinese medicine Compilation & review CONSORT for TCM future development Guidelines as Topic Humans Medicine Medicine & Public Health Medicine, Chinese Traditional - standards Randomized Controlled Trials as Topic - standards Report writing reporting standards Research Report - standards Review |
title | Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T13%3A55%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Consolidated%20standards%20of%20reporting%20trials%20(CONSORT)%20for%20traditional%20Chinese%20medicine:%20current%20situation%20and%20future%20development&rft.jtitle=Frontiers%20of%20medicine&rft.au=Bian,%20Zhaoxiang&rft.date=2011-06-01&rft.volume=5&rft.issue=2&rft.spage=171&rft.epage=177&rft.pages=171-177&rft.issn=2095-0217&rft.eissn=2095-0225&rft_id=info:doi/10.1007/s11684-011-0132-z&rft_dat=%3Cproquest_cross%3E873494750%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1941684904&rft_id=info:pmid/21695622&rfr_iscdi=true |